• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Scientific Publications by FDA Staff

  • Print
  • Share
  • E-mail

Search Publications



Starting Date

Ending Date

Order by

Entry Details

J Pediatric Infect Dis Soc 2019 Oct 23 [Epub ahead of print]

Measles maternal antibodies with low avidity do not interfere with the establishment of robust quantity and quality antibody responses after the primary dose of measles, mumps, and rubella vaccine administered at 12-months of age.

Collins CA, Gelinas L, Yasukawa LL, Audet S, Abu-Raya B, Turvey SE, Beeler JA, Kollmann TR, Gans HA


In this study, we illustrate, for the first time, that preexisting low-avidity neutralizing measles maternal antibodies do not interfere with the development of high concentrations of high-avidity measles antibodies in children immunized at age 12 months. This suggests that the quality of measles maternal antibodies, rather than the quantity, impacts immunogenicity of primary measles immunization.

Category: Journal Article
PubMed ID: #31644795 DOI: 10.1093/jpids/piz074
Includes FDA Authors from Scientific Area(s): Biologics
Entry Created: 2019-04-21 Entry Last Modified: 2019-11-10